World's Best Scientists 2026 revealed!
Bertrand Cariou

Bertrand Cariou

D-Index & Metrics

Medicine

D-Index
79
Citations
24443
World Ranking
17499
National Ranking
582

Overview

Bertrand Cariou is affiliated with the University of Nantes in France. Their research spans multiple fields with a primary focus on Medicine and Biochemistry, Genetics and Molecular Biology. Within these fields, their significant subfields of study include Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Cardiology and Cardiovascular Medicine, and Epidemiology.

Their scientific work covers a range of topics centered around metabolic and cardiovascular health. Main topics documented in their publications include Lipoproteins and Cardiovascular Health, Diabetes Treatment and Management, Liver Disease Diagnosis and Treatment, Diabetes, Cardiovascular Risks, and Lipoproteins, Lipid metabolism and disorders, COVID-19 Clinical Research Studies, and Metabolism, Diabetes, and Cancer.

Bertrand Cariou has contributed to numerous papers, among which key publications are:

  • Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study, 2020, Diabetologia
  • Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study, 2021, Diabetologia
  • Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review, 2021, Diabetes Obesity and Metabolism

Other notable publications in the wider research community relevant to related topics include works on lipid management, metabolic dysregulation in obesity and diabetes, and metabolic disease reviews published in journals such as The Journal of Clinical Endocrinology & Metabolism and The Journal of Experimental Medicine.

Their research outputs have appeared frequently in several scientific journals. The most prolific publication venues include:

  • Atherosclerosis
  • Diabetes & Metabolism
  • Diabetes Obesity and Metabolism
  • Journal of Hepatology
  • Arteriosclerosis Thrombosis and Vascular Biology

Collaboration has been a substantial part of their career. Frequent coauthors include Cédric Le May, Samy Hadjadj, Mikaël Croyal, Matthieu Wargny, and Mathilde Di Filippo, reflecting ongoing partnerships in related areas of research.

Best Publications

  • Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation

    Philippe Lefebvre;Bertrand Cariou;Fleur Lien;Folkert Kuipers

  • PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2) : a randomised, double-blind, placebo-controlled trial

    Frederick J Raal;Evan A Stein;Robert Dufour;Traci Turner

  • Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.

    Bertrand Cariou;Samy Hadjadj;Matthieu Wargny;Matthieu Pichelin

  • The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice

    Bertrand Cariou;Bertrand Cariou;Bertrand Cariou;Kirsten Van Harmelen;Kirsten Van Harmelen;Kirsten Van Harmelen;Daniel Duran-Sandoval;Daniel Duran-Sandoval;Daniel Duran-Sandoval;Theo H. Van Dijk

  • Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease

    J-F Yale;G Bakris;B Cariou;D Yue

  • Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial

    Christopher P. Cannon;Bertrand Cariou;Dirk Blom;James M. McKenney

  • Thiazolidinediones and PPARγ agonists: time for a reassessment

    Bertrand Cariou;Bertrand Cariou;Bernard Charbonnel;Bart Staels;Bart Staels

  • Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)

    Bernard Zinman;Athena Philis-Tsimikas;Bertrand Cariou;Yehuda Handelsman

  • Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial

    Vanita R Aroda;Stephen C Bain;Bertrand Cariou;Milivoj Piletič

  • PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study

    Amand F Schmidt;Daniel I Swerdlow;Daniel I Swerdlow;Michael V Holmes;Michael V Holmes;Riyaz S Patel;Riyaz S Patel

  • Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c

    Philippe Costet;Bertrand Cariou;Gilles Lambert;Florent Lalanne

  • Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

    Bart Staels;Anne Rubenstrunk;Benoit Noel;Géraldine Rigou

  • Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity

    Janne Prawitt;Mouaadh Abdelkarim;Johanna H.M. Stroeve;Iuliana Popescu

  • Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

    Paresh Dandona;Chantal Mathieu;Moshe Phillip;Lars Hansen

  • International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors

    Thomas Danne;Satish Garg;Anne L. Peters;John B. Buse

  • Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.

    J.-F. Yale;G. Bakris;B. Cariou;J. Nieto

  • The Farnesoid X Receptor Modulates Hepatic Carbohydrate Metabolism during the Fasting-Refeeding Transition

    Daniel Duran-Sandoval;Bertrand Cariou;Fredéric Percevault;Nathalie Hennuyer

  • Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects

    Bertrand Cariou;Rémy Hanf;Stéphanie Lambert-Porcheron;Yassine Zaïr

  • Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

    Paresh Dandona;Chantal Mathieu;Moshe Phillip;Lars Hansen

  • Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial

    Bernard Zinman;Vanita R. Aroda;Vanita R. Aroda;John B. Buse;Bertrand Cariou

Frequent Co-Authors

Bart Staels
Bart Staels University of Lille
Folkert Kuipers
Folkert Kuipers University Medical Center Groningen
Helen M. Colhoun
Helen M. Colhoun University of Edinburgh
Lawrence A. Leiter
Lawrence A. Leiter University of Toronto
Robert R. Henry
Robert R. Henry University of California, San Diego
Michel Marre
Michel Marre Université Paris Cité
Fabrice Bonnet
Fabrice Bonnet University of Rennes
Satish K. Garg
Satish K. Garg University of Colorado Anschutz Medical Campus
Jérôme Bertherat
Jérôme Bertherat Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering careers in medicine, there are numerous alternative routes and online programs that can help accelerate your healthcare journey. Many opt for nursing degrees due to their high demand and flexible learning options. For those already holding an RN license and seeking advancement, exploring the online nursing doctorate can lead to advanced roles in clinical leadership, education, or research.

Cost is a significant factor for most students. Thankfully, the cheapest rn to bsn program online options make it easier for practicing nurses to continue their education without a large financial burden.

Aspiring nurses without previous nursing experience or degree should look into direct entry msn programs for non nurses online. These accelerated online programs provide a direct path to a master’s in nursing, even for those coming from unrelated fields.

If you’re seeking less competitive admissions, there are resources highlighting the easiest nursing schools to get into, helping you identify programs that match your qualifications and career goals.

Best Scientists Citing Bertrand Cariou

Trending Scientists